Document is current
Any future updates will be listed below
-
Authors
,
Garcés, Juan-José https://orcid.org/0000-0001-9235-4671
Bretones, Gabriel
Burgos, Leire
Valdes-Mas, Rafael
Puig, Noemi
Cedena, Maria-Teresa
Alignani, Diego
Rodriguez, Idoia
Puente, Diana Álvarez
Álvarez, Miguel-García
Goicoechea, Ibai https://orcid.org/0000-0002-5329-2225
Rodriguez, Sara
Calasanz, Maria-Jose
Agirre, Xabier https://orcid.org/0000-0002-6558-9560
Flores-Montero, Juan https://orcid.org/0000-0002-1119-4387
Sanoja-Flores, Luzalba https://orcid.org/0000-0002-9275-7793
Rodriguez-Otero, Paula
Rios, Rafael
Martinez-Lopez, Joaquin
Millacoy, Pamela
Palomera, Luis
Del Orbe, Rafael https://orcid.org/0000-0002-1240-1958
Pérez-Montaña, Albert
El Omri, Halima
Prosper, Felipe https://orcid.org/0000-0001-6115-8790
Mateos, Maria-Victoria https://orcid.org/0000-0003-2390-1218
Rosiñol, Laura
Blade, Joan
Lahuerta, Juan-Jose
Orfao, Alberto
Lopez-Otin, Carlos https://orcid.org/0000-0001-6964-1904
San Miguel, Jesus F.
Paiva, Bruno https://orcid.org/0000-0003-1977-3815
- License Information
-
More Information
Article History
Received: 16 January 2020
Accepted: 19 May 2020
First Online: 1 June 2020
Compliance with ethical standards
:
: M-JC reports membership on board of directors or advisory committees with Janssen, Celgene, and Novartis. PRO reports membership on board of directors or advisory committees with Janssen, Celgene, Takeda, Amgen, Abbvie, Sanofi, BMS, and Kite Pharma. M-VM reports membership on board of directors or advisory committees with Janssen, Celgene, Takeda, Amgen, Abbvie, GSK, Pharmamar, Mundipharma-EDO, Adaptive, and Seattle-Genetics. LR reports honoraria from Janssen, Celgene, Amgen, and Takeda. JB reports honoraria from Celgene, Amgen, and Janssen. J-JL reports honoraria from and membership on board of directors or advisory committees with Takeda, Amgen, Celgene, and Janssen. JFSM reports consultancy for Bristol-Myers Squibb, Celgene, Novartis, Takeda, Amgen, MSD, Janssen, and Sanofi and membership on board of directors or advisory committees with Takeda. BP honoraria for lectures from and membership on advisory boards with Amgen, Bristol-Myers Squibb, Celgene, Janssen, Merck, Novartis, Roche, and Sanofi; unrestricted grants from Celgene, EngMab, Sanofi, and Takeda; and consultancy for Celgene, Janssen, and Sanofi.
